Dipeptidyl Peptidase-4 Inhibitor–Associated Pancreatic Carcinoma

201528 citationsJournal Article

Authors

Angela Nagel · St. John Fisher College

Nabila Ahmed‐Sarwar · St. John Fisher College

Paul M. Werner · St. John Fisher College

Gabriela C. Cipriano · St. John Fisher College

Robbert P. van Manen

Jack Brown · St. John Fisher College

Abstract

There appears to be a statistical association between DPP-4 inhibitor use and pancreatic carcinoma. Causality cannot be inferred from the data provided. Additional clinical studies are needed to further explore this statistical association.

Topics & Keywords

Peptidase Inhibition and Analysis Pancreatic and Hepatic Oncology Research Diabetes Treatment and Management

UN Sustainable Development Goals

Good health and well-being

Publication Details

Published in: Annals of Pharmacotherapy

Volume 50, Issue 1, pp. 27-31

DOI: 10.1177/1060028015610123

Field-Weighted Citation Impact: 1.29